Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg Tablets Under Fed Conditions
NCT01179659
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
150
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Pantoprazole 40 mg DR Tablet vs. Protonix 40 mg DR Tablet
Sponsor
Kremers Urban Development Company